Marshall Wace North America’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $81.9M | Sell |
451,406
-128,419
| -22% | -$23.3M | 0.35% | 57 |
|
|
2021
Q2 | $117M | Sell |
579,825
-407,463
| -41% | -$82.2M | 0.49% | 40 |
|
|
2021
Q1 | $212M | Buy |
987,288
+272,560
| +38% | +$58.6M | 0.88% | 12 |
|
|
2020
Q4 | $169M | Buy |
714,728
+615,362
| +619% | +$145M | 0.76% | 16 |
|
|
2020
Q3 | $27M | Sell |
99,366
-140,898
| -59% | -$38.3M | 0.17% | 149 |
|
|
2020
Q2 | $69.8M | Sell |
240,264
-47,636
| -17% | -$13.8M | 0.46% | 50 |
|
|
2020
Q1 | $68.5M | Sell |
287,900
-301,418
| -51% | -$71.7M | 0.52% | 57 |
|
|
2019
Q4 | $129M | Sell |
589,318
-163,350
| -22% | -$35.8M | 0.62% | 40 |
|
|
2019
Q3 | $128M | Sell |
752,668
-132,322
| -15% | -$22.4M | 0.73% | 37 |
|
|
2019
Q2 | $162M | Buy |
884,990
+92,983
| +12% | +$17.1M | 1.01% | 22 |
|
|
2019
Q1 | $146M | Buy |
792,007
+291,952
| +58% | +$53.7M | 1.03% | 19 |
|
|
2018
Q4 | $82.9M | Sell |
500,055
-304,706
| -38% | -$50.5M | 0.8% | 29 |
|
|
2018
Q3 | $155M | Sell |
804,761
-583,039
| -42% | -$112M | 1.07% | 21 |
|
|
2018
Q2 | $236M | Buy |
1,387,800
+727,532
| +110% | +$124M | 1.33% | 8 |
|
|
2018
Q1 | $108M | Sell |
660,268
-162,620
| -20% | -$26.5M | 0.54% | 38 |
|
|
2017
Q4 | $123M | Buy |
822,888
+256,709
| +45% | +$38.5M | 0.68% | 23 |
|
|
2017
Q3 | $86.1M | Buy |
566,179
+145,864
| +35% | +$22.2M | 0.54% | 20 |
|
|
2017
Q2 | $54.2M | Sell |
420,315
-4,248
| -1% | -$548K | 0.4% | 55 |
|
|
2017
Q1 | $46.3M | Buy |
+424,563
| New | +$46.3M | 0.37% | 79 |
|